(Q38523681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Nanocarriers for cancer-targeted drug delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Preeti Kumari

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Swati Biswas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

10 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

Journal of Drug Targeting

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

179-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26061298%20AND%20SRC:MED&resulttype=core&format=json

Principles of cancer therapy: oncogene and non-oncogene addiction

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Polymeric micelles for delivery of poorly water-soluble compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Cancer-targeted polymeric drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanopreparations for organelle-specific delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Tumor delivery of macromolecular drugs based on the EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

The cancer anorexia/weight loss syndrome: therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Drug-like properties and the causes of poor solubility and poor permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

PEG-based micelles as carriers of contrast agents for different imaging modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Therapeutic nanoparticles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Doxil®--the first FDA-approved nano-drug: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Passive and active drug targeting: drug delivery to tumors as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Multifaceted transport characteristics of nanomedicine: needs for characterization in dynamic environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Lipid nanocapsules: a new platform for nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Aptamers as therapeutic and diagnostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Design of folic acid-conjugated nanoparticles for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Liposomal drug delivery systems: an update review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nano-oncology: drug delivery, imaging, and sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

The development of site-specific drug delivery nanocarriers based on receptor mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Nanotech approaches to drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Dendrimers in drug research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Dendrimers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Dendrimers in biomedical applications--reflections on the field

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Dendrimers and dendritic polymers in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Preparation of carbon nanotube bioconjugates for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Drug delivery with carbon nanotubes for in vivo cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Multiplexed toxin analysis using four colors of quantum dot fluororeagents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

A DNA-based method for rationally assembling nanoparticles into macroscopic materials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Gold nanoshell bioconjugates for molecular imaging in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Recent advances in iron oxide nanocrystal technology for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049

Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2015.1051049